The Drugs Controller General of India (DCGI) approved the Serum Institute's coronavirus vaccine 'Covishield' and Bharat Biotech's 'Covaxin', making them India's first vaccines against the pandemic.

India: DCGI approves Serum & Bharat Biotech vaccines for emergency use

The Oxford Vaccine is one step away from a rollout in India. Sources tell WION that an expert panel has cleared the shot. Palki Sharma tells you more.

Gravitas: Oxford Vaccine, One step away from approval in India

Indian panel recommends emergency use of AstraZeneca COVID vaccine with conditions

India's SEC to decide on approving Serum Institute of India's Covishield vaccine for emergency use authorisation

Indian Pharmaceuticals firm Bharat Biotech is seeking emergency authorisation of its Coronavirus vaccine 'Covaxin'. This comes after Pfizer & Serum institute producing AstraZeneca vaccine have applied for the emergency use authorisation from DGCI.

India: Bharat Biotech latest to seek emergency use authorisation

The Serum Institute of India (SII) on Sunday became the first indigenous company to apply to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for the Oxford COVID-19 vaccine 'Covishield' in the country,

News Alert: Serum institute seeks emergency use nod for 'Covishield' vaccine in India

Foreign envoys to visit Pune on Dec 4 to see India's COVID-19 vaccine programme

covishield

Covishield, News on Covishield, stories on Covishield, articles on Covishield, Covishield stories at Wion, Covishield news, Covishield latest news